Paper2437282
In vivo pharmacology of L-364,718, a new potent nonpeptide peripheral cholecystokinin antagonist.
Lotti VJ and 5 others. J Pharmacol Exp Ther, 1987. Cited by 163 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. In vivo pharmacology of L-364,718, a new potent nonpeptide peripheral cholecystokinin antagonist. Papers, record 2437282. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2437282
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- In vivo pharmacology of L-364,718, a new potent nonpeptide peripheral cholecystokinin antagonist.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Benzodiazepinones | Major topic |
| Cholecystokinin | Major topic |
| Amylases | |
| Animals | |
| Cats | |
| Colon | |
| Devazepide | |
| Dogs | |
| Eating | |
| Female | |
| Gallbladder | |
| Gastric Emptying | |
| Mice | |
| Muscle Contraction | |
| Pancreatic Polypeptide | |
| Rats | |
| Rats, Inbred Strains | |
| Sincalide |
Source PubMed
Cited by25
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 163 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 32256672 | Anorexic and metabolic effect of jojoba: potential treatment against metabolic syndrome and hepatic complications. | Nutr Metab (Lond) | 2020 | https://conductscience.org/library/papers/32256672 | PubMed |
| 20001102 | A potential gastrointestinal link between enhanced postnatal maternal care and reduced anxiety-like behavior in adolescent rats. | Behav Neurosci | 2009 | https://conductscience.org/library/papers/20001102 | PubMed |
| 18480241 | Salmon calcitonin reduces food intake through changes in meal sizes in male rhesus monkeys. | Am J Physiol Regul Integr Comp Physiol | 2008 | https://conductscience.org/library/papers/18480241 | PubMed |
| 9834374 | Mechanisms of insulin-induced relaxation of the canine proximal stomach after proximal gastric vagotomy. | J Gastrointest Surg | 1997 | https://conductscience.org/library/papers/9834374 | PubMed |
| 9457654 | Cholecystokinin (CCK) regulates somatostatin secretion through both the CCK-A and CCK-B/gastrin receptors in sheep. | J Physiol | 1997 | https://conductscience.org/library/papers/9457654 | PubMed |
| 9149042 | Gastric emptying in OLETF rats not expressing CCK-A receptor gene. | Dig Dis Sci | 1997 | https://conductscience.org/library/papers/9149042 | PubMed |
| 9013282 | The cholecystokinin receptor antagonist L-364,718 reduces taurocholate-induced pancreatitis in rats. | Int J Pancreatol | 1996 | https://conductscience.org/library/papers/9013282 | PubMed |
| 8943969 | Intraduodenal lipid does not inhibit acid secretion in OLETF rats not expressing CCK-A receptor gene. | Dig Dis Sci | 1996 | https://conductscience.org/library/papers/8943969 | PubMed |
| 8680546 | Duration of anti-cholecystokinin (CCK) action on the rat exocrine pancreas of new CCK receptor antagonist FK480 administered orally. | J Gastroenterol | 1996 | https://conductscience.org/library/papers/8680546 | PubMed |
| 7956596 | Physiological role of cholecystokinin on gastric emptying and acid output in dogs. | Dig Dis Sci | 1994 | https://conductscience.org/library/papers/7956596 | PubMed |
| 7923559 | Enhancement of the cytotoxicity of cisplatin by the cholecystokinin antagonist MK-329 in a human pancreatic cancer cell line. | Cancer Chemother Pharmacol | 1994 | https://conductscience.org/library/papers/7923559 | PubMed |
| 7895561 | Cholecystokinin is a potent protective agent against alcohol-induced gastric injury in the rat. Role of endogenous prostaglandins. | Dig Dis Sci | 1995 | https://conductscience.org/library/papers/7895561 | PubMed |
| 2920915 | Effects of non-peptidal CCK receptor antagonist (L-364,718) on pancreatic responses to cholecystokinin, gastrin, bombesin, and meat feeding in dogs. | Gut | 1989 | https://conductscience.org/library/papers/2920915 | PubMed |
| 2794058 | Effects of a novel cholecystokinin (CCK) receptor antagonist, MK-329, on gallbladder contraction and gastric emptying in humans. Implications for the physiology of CCK. | J Clin Invest | 1989 | https://conductscience.org/library/papers/2794058 | PubMed |
| 2758237 | Cholecystokinin-octapeptide constricts guinea-pig and human airways. | Br J Pharmacol | 1989 | https://conductscience.org/library/papers/2758237 | PubMed |
| 2646088 | L-364,718, a new CCK antagonist, inhibits postprandial pancreatic secretion and PP release in dogs. | Dig Dis Sci | 1989 | https://conductscience.org/library/papers/2646088 | PubMed |
| 2614728 | Cholecystokinin receptor antagonism by peptidergic and non-peptidergic agents in rat pancreas. | J Physiol | 1989 | https://conductscience.org/library/papers/2614728 | PubMed |
| 2390924 | Feline cholescintigraphy. Studies on role of cholecystokinin in regulation of gallbladder function. | Dig Dis Sci | 1990 | https://conductscience.org/library/papers/2390924 | PubMed |
| 2331576 | Reversal of the anorectic effect of (+)-fenfluramine in the rat by the selective cholecystokinin receptor antagonist MK-329. | Br J Pharmacol | 1990 | https://conductscience.org/library/papers/2331576 | PubMed |
| 2312719 | Effects of a cholecystokinin receptor antagonist on intestinal phase of pancreatic and biliary responses in man. | J Clin Invest | 1990 | https://conductscience.org/library/papers/2312719 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2437282
GET https://conductscience.org/api/papers/v1/2437282/cited_by?page=2